Oscar Health, Inc. (NYSE:OSCR) Position Raised by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC lifted its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 24.2% in the 4th quarter, Holdings Channel reports. The fund owned 57,850 shares of the company’s stock after buying an additional 11,282 shares during the period. Janney Montgomery Scott LLC’s holdings in Oscar Health were worth $778,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of OSCR. State Street Corp boosted its stake in Oscar Health by 6.0% during the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after purchasing an additional 291,335 shares during the period. Geode Capital Management LLC raised its holdings in shares of Oscar Health by 11.7% during the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after buying an additional 455,205 shares during the last quarter. Hennessy Advisors Inc. boosted its position in shares of Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Oscar Health by 68.5% during the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock worth $48,977,000 after buying an additional 938,742 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Oscar Health by 20.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after buying an additional 270,223 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analysts Set New Price Targets

OSCR has been the subject of several research analyst reports. Jefferies Financial Group assumed coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective for the company. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $21.56.

Oscar Health Trading Down 0.4 %

Shares of NYSE:OSCR opened at $14.72 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $3.64 billion, a price-to-earnings ratio of -245.21, a PEG ratio of 0.67 and a beta of 1.73. Oscar Health, Inc. has a 1-year low of $13.05 and a 1-year high of $23.79. The company has a 50 day moving average price of $15.09 and a 200 day moving average price of $16.82.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. On average, research analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Insider Activity at Oscar Health

In related news, COO Steven Wolin sold 19,580 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $354,006.40. Following the completion of the sale, the chief operating officer now owns 102,598 shares in the company, valued at approximately $1,854,971.84. This represents a 16.03 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the stock in a transaction on Tuesday, November 12th. The shares were purchased at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the transaction, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.